학술논문

ERAS-601, a potent allosteric inhibitor of SHP2, demonstrates anti-tumor activity in RAS/MAPK-driven tumor models
Document Type
Journal
Source
CANCER RESEARCH; JUN 15 2022, 82 12, 1p. Supplement: S
Subject
Language
English
ISSN
15387445